Véronique Durand

587 total citations
18 papers, 423 citations indexed

About

Véronique Durand is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Véronique Durand has authored 18 papers receiving a total of 423 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 7 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Molecular Biology. Recurrent topics in Véronique Durand's work include Monoclonal and Polyclonal Antibodies Research (7 papers), Cell Adhesion Molecules Research (5 papers) and T-cell and B-cell Immunology (5 papers). Véronique Durand is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (7 papers), Cell Adhesion Molecules Research (5 papers) and T-cell and B-cell Immunology (5 papers). Véronique Durand collaborates with scholars based in France, Canada and Brazil. Véronique Durand's co-authors include E. Martini, Catherine Johanet, Jean‐Claude Homberg, N Abuaf, Florence M.G. Cavalli, Étienne Lemieux, Sébastien Bergeron, Nathalie Rivard, Pierre Youinou and Caroline Saucier and has published in prestigious journals such as The Journal of Immunology, Hepatology and International Journal of Cancer.

In The Last Decade

Véronique Durand

18 papers receiving 412 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Véronique Durand France 9 153 142 112 73 66 18 423
S. Sulfaro Italy 9 171 1.1× 82 0.6× 185 1.7× 32 0.4× 49 0.7× 13 564
C. I. Amos United States 6 59 0.4× 53 0.4× 90 0.8× 126 1.7× 123 1.9× 7 393
MY Hsieh Taiwan 9 321 2.1× 268 1.9× 91 0.8× 94 1.3× 62 0.9× 11 512
Gillian McNab United Kingdom 10 162 1.1× 97 0.7× 187 1.7× 235 3.2× 24 0.4× 11 620
Jieyue Liao China 8 79 0.5× 61 0.4× 147 1.3× 178 2.4× 137 2.1× 17 421
H C Hsu Taiwan 10 78 0.5× 64 0.5× 155 1.4× 36 0.5× 26 0.4× 16 419
P. Kahl Germany 6 82 0.5× 154 1.1× 125 1.1× 21 0.3× 26 0.4× 8 378
Juliane Friemel Switzerland 10 159 1.0× 93 0.7× 145 1.3× 46 0.6× 11 0.2× 17 465
Louis Savas United States 14 43 0.3× 73 0.5× 93 0.8× 81 1.1× 20 0.3× 18 437

Countries citing papers authored by Véronique Durand

Since Specialization
Citations

This map shows the geographic impact of Véronique Durand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Véronique Durand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Véronique Durand more than expected).

Fields of papers citing papers by Véronique Durand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Véronique Durand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Véronique Durand. The network helps show where Véronique Durand may publish in the future.

Co-authorship network of co-authors of Véronique Durand

This figure shows the co-authorship network connecting the top 25 collaborators of Véronique Durand. A scholar is included among the top collaborators of Véronique Durand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Véronique Durand. Véronique Durand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Bergeron, Sébastien, Étienne Lemieux, Véronique Durand, et al.. (2010). The serine protease inhibitor serpinE2 is a novel target of ERK signaling involved in human colorectal tumorigenesis. Molecular Cancer. 9(1). 271–271. 57 indexed citations
3.
Lemieux, Étienne, Sébastien Bergeron, Véronique Durand, et al.. (2009). Constitutively active MEK1 is sufficient to induce epithelial‐to‐mesenchymal transition in intestinal epithelial cells and to promote tumor invasion and metastasis. International Journal of Cancer. 125(7). 1575–1586. 67 indexed citations
4.
Lemarié, Claude, et al.. (2009). A new single-platform method for the enumeration of CD34+ cells. Cytotherapy. 11(6). 804–806. 7 indexed citations
5.
Durand, Véronique. (2005). Grossesse à l’adolescence. Lusotopie. XII(1-2). 161–173. 1 indexed citations
6.
Youinou, Pierre, et al.. (2002). Pathogenic effects of anti-Fc gamma receptor IIIb (CD16) on polymorphonuclear neutrophils in non-organ-specific autoimmune diseases. Autoimmunity Reviews. 1(1-2). 13–19. 10 indexed citations
7.
Benderitter, Marc, et al.. (2002). Clearance of Radiation-Induced Apoptotic Lymphocytes:Ex VivoStudies and anIn VitroCo-culture Model. Radiation Research. 158(4). 464–474. 15 indexed citations
8.
Durand, Véronique, Yves Renaudineau, Jacques‐Olivier Pers, Pierre Youinou, & Christophe Jamin. (2001). Cross-Linking of Human FcγRIIIb Induces the Production of Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating Factor by Polymorphonuclear Neutrophils. The Journal of Immunology. 167(7). 3996–4007. 21 indexed citations
9.
Durand, Véronique, Jacques‐Olivier Pers, Yves Renaudineau, et al.. (2001). Differential effects of anti-FcγRIIIb autoantibodies on polymorphonuclear neutrophil apoptosis and function. Journal of Leukocyte Biology. 69(2). 233–240. 6 indexed citations
10.
Durand, Véronique, Jacques‐Olivier Pers, Yves Renaudineau, Pierre Youinou, & Christophe Jamin. (2001). Soluble Fcγ receptor IIIb alters the function of polymorphonuclear neutrophils but extends their survival. European Journal of Immunology. 31(7). 1952–1961. 6 indexed citations
11.
Durand, Véronique, Jacques‐Olivier Pers, Yves Renaudineau, et al.. (2001). Differential effects of anti-Fc gamma RIIIb autoantibodies on polymorphonuclear neutrophil apoptosis and function.. PubMed. 69(2). 233–40. 8 indexed citations
12.
Durand, Véronique, et al.. (2000). [Who uses the public health service? An example from North-East Brazil].. PubMed. 10(2). 141–4. 1 indexed citations
13.
Durand, Véronique, A. Lamour, Valérie Devauchelle, Pierre Youinou, & Christophe Jamin. (2000). Fc-Gamma Receptor Reactivity in Nonorgan-Specific Autoimmune Diseases. Clinical Reviews in Allergy & Immunology. 18(1). 11–26. 6 indexed citations
14.
Bodman‐Smith, Mark, Arthi Anand, Véronique Durand, Pierre Youinou, & Peter M. Lydyard. (2000). Decreased expression of FcγRIII (CD16) by γδ T cells in patients withrheumatoid arthritis. Immunology. 99(4). 498–503. 11 indexed citations
15.
Durand, Véronique, et al.. (2000). CD45 autoantibodies mediate neutralization of activated T cells from lupus patients through anergy or apoptosis. Lupus. 9(8). 622–631. 4 indexed citations
16.
Durand, Véronique, et al.. (2000). Abnormal distribution of CD45 isoforms expressed by CD4+ and CD8+ T cells in rheumatoid arthritis.. PubMed. 15(2). 587–91. 16 indexed citations
17.
Durand, Véronique, et al.. (1993). Mise au point d'une technique de dosage immuno-enzymatique de type ELISA pour la détection des anticorps anti-SSB. Étude comparative de 2 trousses. La Revue de Médecine Interne. 14(5). 288–293. 2 indexed citations
18.
Martini, E., N Abuaf, Florence M.G. Cavalli, et al.. (1988). Antibody to liver cytosol (anti-LC1) in patients with autoimmune chronic active hepatitis type 2. Hepatology. 8(6). 1662–1666. 160 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S. Sulfaro Breakdown of academic impact, for papers by C. I. Amos Breakdown of academic impact, for papers by MY Hsieh Breakdown of academic impact, for papers by Gillian McNab Breakdown of academic impact, for papers by Jieyue Liao Breakdown of academic impact, for papers by H C Hsu Breakdown of academic impact, for papers by P. Kahl Breakdown of academic impact, for papers by Juliane Friemel Breakdown of academic impact, for papers by Louis Savas
Rankless by CCL
2026